“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Dec 31, 2020
Part IV: Escalating Assault on 340B Program for Providers Serving America’s… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Dec 30, 2020
Part III: Angling to Price-Gouge American Public on COVID-19 Treatments… Read More
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Dec 29, 2020
Part II: Gaming the System to Undermine Competition at the Expense of American… Read More
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Dec 28, 2020
Part I: Sticking with Price-Hiking “Business-as-Usual” During Pandemic… Read More
TWO BIRDS OF A FEATHER: ASTRAZENECA TO ACQUIRE FELLOW PRICE-GOUGER ALEXION IN MULTI-BILLION DOLLAR DEAL
Dec 14, 2020
In case you missed it, Big Pharma giant AstraZeneca announced plans to acquire… Read More
REMINDER: REBATE RULE WOULD DO NOTHING TO LOWER DRUG PRICES WHILE HIKING PREMIUMS ON SENIORS AND COSTING TAXPAYERS $200 BILLION
Nov 16, 2020
Administration Should Abandon Misguided Policy That Rewards Drug Companies’… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA & BRISTOL-MYERS SQUIBB
Nov 5, 2020
Big Pharma Completes Sweep of Beating Wall Street Expectations After 2020… Read More
BIG PHARMA EARNINGS WATCH: AMGEN & SANOFI
Nov 5, 2020
Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giants… Read More
SECOND OPINION: BIG PHARMA GAMES THE PATENT SYSTEM TO HIKE PRICES AND BOOST PROFITS — NOT ‘DRIVE INNOVATION’ OR ‘ENHANCE PATIENT ACCESS’
Oct 29, 2020
Drug Companies’ Anti-Competitive Gamesmanship Comes At Tremendous Cost To… Read More
BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE
Oct 29, 2020
Brand Name Big Pharma Giant Surpasses Expectations After Hiking Prices A new… Read More
BIG PHARMA EARNINGS WATCH: MERCK, NOVARTIS & PFIZER
Oct 28, 2020
Brand Name Drug Companies Beat Wall Street Expectations After Repeatedly… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Oct 13, 2020
Price Hikes Fuel Q3 Earnings Beat For Brand Name Giant As millions of… Read More